Global MRSA Drugs Market 2016-2020

Table of Contents

PART 01: Executive summary

• Highlights

PART 02: Scope of  the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Key buying criteria

PART 06: Antibacterial: Overview

• Introduction
• MOA
• General principles for use of antibiotics
• Clinical uses

PART 07: Antimicrobial resistance

• Sources of spread of resistant organisms
• Initiatives to improve antibiotic innovation
• Surveillance systems for antibiotic resistance

PART 08: Legislation relating to antibiotics use in US

PART 09: Pipeline analysis

• Solithromycin
• TD-1792
• Baxdela
• Taksta

PART 10: Market landscape

• Global antibacterial drugs market
• Global MRSA drugs market
• Five forces analysis

PART 11: Market segmentation by drug class

• Tetracycline
• Folate antagonists
• Cephalosporin
• Lipopeptide
• Oxazolidinone
• Lipoglycopeptide

PART 12: Market segmentation by drug origin

• Semisynthetic drugs
• Synthetic drugs

PART 13: Market segmentation by MOA

• Bacteriostatic
• Bactericidal

PART 14: Geographical segmentation

• Global MRSA drugs market by geographical segmentation 2015-2020
• MRSA drugs market in Americas
• MRSA drugs market in EMEA
• MRSA drugs market in APAC

PART 15: Market drivers

• Special regulatory designations
• Increasing prevalence of infections
• Growing awareness of diseases
• Rise in older population

PART 16: Impact of drivers

PART 17: Market challenges

• Development of drug-resistant strains
• Patent expiries and generic penetration
• Decreased investments in research activities

PART 18: Impact of drivers and challenges

PART 19: Market trends

• Strategic alliances and M&A
• Patient assistance programs
• Increased funding for antibiotic research

PART 20: Vendor landscape

• Competitive scenario
• Key vendor profiles
• Allergan
• Merck
• Pfizer
• Theravance
• Other prominent vendors

PART 21: Appendix

• List of abbreviations

PART 22: Explore Technavio